Quest Diagnostics
714 hedge funds and large institutions have $9.91B invested in Quest Diagnostics in 2020 Q1 according to their latest regulatory filings, with 111 funds opening new positions, 256 increasing their positions, 243 reducing their positions, and 100 closing their positions.
44% more call options, than puts
Call options by funds: $77.9M | Put options by funds: $54.1M
11% more first-time investments, than exits
New positions opened: 111 | Existing positions closed: 100
4.14% more ownership
Funds ownership: 88.94% → 93.08% (+4.1%)
5% more repeat investments, than reductions
Existing positions increased: 256 | Existing positions reduced: 243
0% more funds holding
Funds holding: 711 → 714 (+3)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
22% less capital invested
Capital invested by funds: $12.8B → $9.91B (-$2.87B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$314M |
| 2 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$142M |
| 3 |
SI
Scharf Investments
Los Gatos,
California
|
+$73.7M |
| 4 |
JP Morgan Chase
New York
|
+$70.3M |
| 5 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
+$42.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$212M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$110M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$52.4M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$46.9M |
| 5 |
Goldman Sachs
New York
|
-$43.1M |
DGX Hedge Fund Activity: Q1 2020 in Review
714 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2020, worth a combined $9.91B — down 22% from $12.8B a quarter earlier.
Buyers outnumbered sellers: 111 funds opened new DGX positions and 100 closed out — a net gain of 11 holders — while 256 added to existing stakes and 243 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $314M. The largest seller was Boston Partners, exiting entirely with an estimated $212M sold.
- 714 institutional investors held Quest Diagnostics (DGX) as of Q1 2020, up from 711 in Q4 2019.
- Funds reported $9.91B of Quest Diagnostics stock for Q1 2020, down 22% quarter-over-quarter.
- 111 funds opened new Quest Diagnostics positions in Q1 2020 and 100 closed out, a net change of +11 holders.
- The largest Quest Diagnostics buyer in Q1 2020 was Victory Capital Management, an estimated $314M added.
- The largest Quest Diagnostics seller in Q1 2020 was Boston Partners, an estimated $212M sold.
Based on aggregated 13F filings for Q1 2020.